Pages

.

Showing posts with label metrics. Show all posts
Showing posts with label metrics. Show all posts

RightBio Metrics Introduces New FDA Cleared Point-of-Care Devices to Provide Safer, Cleaner and More Accurate Gastric pH Readings

RightBio Metrics introduces three new devices to provide safer, cleaner and more accurate gastric pH readings: RightSpot pH Indicator, RightSpot Infant pH Indicator and RightLevel pH Detector. (PRNewsFoto/RightBio Metrics)jwplayer.key="2kY/GKwZ2uQZmDlQ9VYArfZt2b4+KhHX3+DM4zisgtE=";PHOENIX, June 11, 2014 /PRNewswire/ -- RightBio Metrics, an emerging leader in advanced fluid measurement technologies, today announces the availability of three new products after receiving both FDA and CE Mark approvals to distribute their point-of-care diagnostic devices. The approved devices, designed to provide safer nasogastric (NG) tube placement and accurate gastric acidity measurement using an innovative in vitro pH indicator include, RightSpot pH Indicator, RightSpot Infant pH Indicator and RightLevel pH Detector.

Housed under the brand RightpH, the technologies accurately measure bio fluids at the bedside to enhance the speed and quality of medical treatment. They are safer, cleaner and more accurate than pH paper test strips used today, giving clinicians additional confidence in NG tube placement, and treatment decisions, without incurring substantial costs to verify placement using X-rays or fumbling with messy manual paper tests.

The RightSpot pH Indicator and RightSpot Infant pH Indicator are small, non-invasive devices that are used to verify gastric acidity to avoid misplacement of NG feeding/suction tubes and percutaneous endoscopic gastrostomy (PEG) tubes. The third device, the RightLevel pH Detector, quickly measures stomach pH levels of critically ill patients to aid in proper medication dosage for treating gastric ulcers and bleeding. All three products have received CLIA Waived status, which means the FDA has classified them as simple laboratory examinations and procedures that have an insignificant risk of an erroneous result, which makes it easier for hospitals to perform onsite and maintain per CAP regulations.

"As an emergency room physician, I experienced firsthand the devastating effects of improper NG tube placement and uncertainty about treatment-critical metrics due to antiquated technology. Seeing patients put at unnecessary risk ignited my passion to make much needed fluid measurement technology improvements," said Paul Gilbert, MD, co-founder and president, RightBio Metrics.

Roughly 12.6 million NG tubes were placed in 2012 in the U.S. alone and studies show between two and four percent were misplaced. Misplaced tubes are typically misguided into the lungs causing significant morbidity and mortality and costing medical providers millions of dollars. In fact, from 2001 to 2011, medical providers in the Chicago area paid more than 10 million dollars to resolve lawsuits filed for injuries and deaths caused by misplaced NG feeding and suction tubes.

"Care providers are continuously looking for solutions that combine quality improvement with financial responsibility. RightpH devices help clinicians put science into decision-making and increase certainty about tube placement and treatment decisions without losing critical time," stated Gilbert. "RightpH indicators also help hospitals save important resources by lowering the risk of readmission and malpractice claims, which position themselves as leaders in patient safety and clinician practice conditions."

Gilbert added, "In medicine, quick decisions have to be made in treatment environments that often do not permit the use of expensive equipment. While pH measurement has become standard practice to ensure better treatment, RightpH offers the first safe and efficient technologies for easy pH measurement. We're excited to equip providers with these valuable tools to help eliminate any further NG tube misplacements or mistreatment."

About RightBio Metrics
RightBio Metrics is an emerging leader in advanced bio fluid measurement technologies. The company's RightpH line of products accurately measure bodily fluid metrics to enhance the speed and quality of medical treatment at the point-of-care and reduce healthcare costs associated with mistreatment and alternative verification methods. To learn more, please visit RightBioMetrics.com.

Photo - http://photos.prnewswire.com/prnh/20140610/116838

SOURCE RightBio Metrics

RELATED LINKS
http://www.rightbiometrics.com

reade more... Résuméabuiyad

Protein Metrics Expands Biopharmaceutical Software Suite with Launch of Byomap™ Software

Protein Metrics Byomap(TM) software, developed in close collaboration with biopharmaceutical researchers, facilitates quick annotation of peptide maps and rapid, quantitative comparison of multiple data traces against a reference material. ...jwplayer.key="2kY/GKwZ2uQZmDlQ9VYArfZt2b4+KhHX3+DM4zisgtE=";SAN CARLOS, Calif., March 24, 2014 /PRNewswire-iReach/ -- Protein Metrics Inc., a leading provider of software for rapid and thorough protein characterization, today announced the release of Byomap™ software for advanced peptide mapping. Byomap facilitates quick annotation of peptidemaps and rapid, quantitative comparison of multiple data traces against a reference material. Byomap is an extension of Protein Metrics' biopharmaceutical suite of products that includes their Byologic™ software, which enables researchers to confidently characterize their product down to trace components identifying degadants, impurities, post-translational modifications and sequence variants.

(Photo: http://photos.prnewswire.com/prnh/20140324/MN87673)

"We are excited to expands our biopharmaceutical portfolio and provide a new, advanced peptide mapping tool to help biopharmaceutical researchers characterize their therapeutic proteins," said Chris Becker, Ph.D., President and CEO of Protein Metrics. "Byomap's convenient annotation and comparison capabilities enable our customers to quickly report on comparability and advance their Quality by Design (QbD) initiatives to track quality attributes as their products move through development."

Originally developed in close collaboration with biopharmaceutical researchers, Byomap begins the quantitative evaluation of chromatograms by first detecting peaks, then performing automatic baseline and peak area determinations. Annotation is rapid with the aid of novel visualization tools. Byomap can simultaneously align and quantitatively compare up to ten peptide maps to an annotated reference map, flagging peaks with out-of-tolerance intensities. It can also be used to analyze other types of chromatograms such as for detached glycans. The software has sophisticated export features for figures and tables that can be used directly in regulatory filings.

About Protein Metrics

Protein Metrics is a privately held software company serving biopharmaceutical development professionals and proteomics researchers. The company focuses on the analysis of mass spectrometric and other analytical data on proteins and glycans. Seeking to ensure that software to analyze mass spec and other analytical data keeps pace with the rapid advances in analytical instrumentation, Protein Metrics leverages its experience in analytical chemistry, bioinformatics, and computer science to make analytical results more complete, sensitive, accurate, and easier to achieve. Protein Metrics products are built on collaborations with pharmaceutical research scientists and years of research on proteins and glycans. The company is headquartered in San Carlos, California. For more information, visit www.proteinmetrics.com.

Media Contact: Eric Carlson, Protein Metrics, Inc., 408-600-5540, carlson@proteinmetrics.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

SOURCE Protein Metrics, Inc.

RELATED LINKS
http://www.proteinmetrics.com

reade more... Résuméabuiyad

Protein Metrics Launches Byologic™ Software for Therapeutic Proteins

Byologic™ was originally developed in close collaboration with biopharmaceutical researchers. (PRNewsFoto/Protein Metrics, Inc.)jwplayer.key="2kY/GKwZ2uQZmDlQ9VYArfZt2b4+KhHX3+DM4zisgtE=";SAN CARLOS, Calif., March 12, 2014 /PRNewswire-iReach/ -- Protein Metrics, Inc., a leading provider of software for rapid and thorough protein characterization, today announced the release of Byologic. Byologic software enables easy and convenient identification and quantification of sequence variants, protein modifications, and degradants down to trace concentrations. 

(Photo - http://photos.prnewswire.com/prnh/20140312/MN79867)

"We are focused on software products that improve analytical quality and keep pace with recent advances seen in analytical instrumentation, allowing biopharmaceutical companies to manage the risk of variants and contaminants in their products," said Chris Becker, Ph.D., President and CEO of Protein Metrics. "Byologic enables our customers to confidently and quickly perform these critical analyses, dramatically shortening development timelines and reducing FTE costs."

Originally developed in close collaboration with leading biopharmaceutical researchers, Byologic also enables rapid evaluation of similarity by a variety of interactive computational and visual inspection tools. Special attention has been paid to the export of well-formatted figures and tables needed for regulatory filings.  

About Protein Metrics

Protein Metrics is a privately held company serving biopharmaceutical development professionals and proteomics researchers, focusing on the analysis of mass spectrometric and other analytical data on proteins and glycans. Seeking to ensure that software keeps pace with the rapid advances in analytical instrumentation, Protein Metrics leverages its experience in analytical chemistry, bioinformatics, and computer science to make analytical results more complete, sensitive, accurate, and easier to achieve. Protein Metrics products are built on collaborations with pharmaceutical research scientists and years of research in proteomics and glycomics. The company is headquartered in San Carlos, California. For more information, visit www.proteinmetrics.com.

Media Contact: Eric Carlson, Protein Metrics, Inc., 408-600-5540, carlson@proteinmetrics.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

SOURCE Protein Metrics, Inc.

RELATED LINKS
http://www.proteinmetrics.com

reade more... Résuméabuiyad

HCD Research presents cognitive and metrics of Neuromarketing

HCD Research Logo. (PRNewsFoto/HCD Research) jwplayer. key = ' 2k?/GKwZ2uQZmDlQ9VYArfZt2b4 + KhHX3 + DM4zisgtE = ";FLEMINGTON, N.j., 06 March of 2014/PRNewswire /-HCD Research now offers neuromarketing accessible and useful: the EmCode ™ Neurocognitive metric. These metrics synthesize data Psychophysiological and cognitive to provide two scores for easy comparison against benchmarks HCD Research.

The cognitive element of Neurocognitive EmCode ™ metrics is the HCD Research advertising impact Score (AIS), which has been used for several years to record and compare the cognitive impact of print media and video. Now joined with the score developed recently impact biometric (BIS), the sellers have a way to evaluate both conscious and subconscious responses to various advertising efforts.

BIS assesses three key attributes Psychophysiological Classifieds:

Stop power sustained positive commitment marks ImmersionUnder the direction of Paul Bolls, Co-Director of the laboratory of PRIME in the school of journalism at Missouri and scientific advisor of HCD Research, a team of experts has developed a measure of true to stop cardiac deceleration, excitement and emotion in the initial exposure to an ad for follow-up. Similar Psychophysiological measures are caught throughout display to extrapolate the levels of sustained attention, excitement and the intensity and the direction of emotional response strength. Finally, accurate physiological measures during exposure to brand elements are used to determine if information has been encoded and grade has occurred that a favorable response to the brand.

Using a complex algorithm, each factor is given a specific weight depending on whether it is a static ad or animation or video. This result may be compared then HCD Research benchmarks to determine if the ad is more or less effective than others in the same industry. As powerful as a stand-alone tool, Neurocognitive EmCode ™ metrics combine neurological and cognitive outcomes to provide the most accurate competitive assessment ad.

Subconscious responses to advertising may have significant implications for consumer purchase decisions. As a result, it is essential to determine whether an advertisement is able to capture the attention in a cluttered advertising environment and promote a lasting and positive association with the brand. This combination of score announcement does just that.

As Glenn Kessler, President of HCD Research, explains, "the most recent metrics reveals how effectively an ad can attract attention, maintain attention and evoke an emotional response positive, especially during times of brand".

Logo - http://photos.prnewswire.com/prnh/20071204/NYTU133LOGO

SOURCE HCD Research

reade more... Résuméabuiyad